Infliximab

Overview

Infliximab is a chimeric monoclonal antibody that inhibits tumor necrosis factor-alpha (TNFα), a substance in the body that causes inflammation. It is used in the treatment of autoimmune diseases such as Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriasis, and rheumatoid arthritis.

Therapeutic areas